HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong-Cheng Wang Selected Research

Suspensions

5/2005Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong-Cheng Wang Research Topics

Disease

4Neutropenia
06/2005 - 02/2005
2Heart Failure
03/2020 - 01/2019
2Atherosclerosis
01/2020 - 01/2020
2Neoplasms (Cancer)
07/2014 - 06/2005
2Thrombocytopenia (Thrombopenia)
05/2005 - 03/2005
1Hypesthesia (Numbness)
06/2021
1Spondylosis
06/2021
1Radiculopathy (Radiculopathy, Cervical)
06/2021
1Alopecia Areata
11/2019
1Unstable Angina
01/2019
1Hypertrophy
01/2019
1Fibrosis (Cirrhosis)
01/2019
1Inflammation (Inflammations)
01/2019
1Multiple Sclerosis
06/2012
1Febrile Neutropenia
06/2005
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2005
1Infections
06/2005
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2005
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
05/2005
1Refractory Anemia
05/2005
1Injection Site Reaction
03/2005
1Purpura
03/2005
1Ecchymosis
03/2005
1Dizziness (Lightheadedness)
03/2005
1Diarrhea
03/2005
1Constipation
03/2005
1Arthralgia (Joint Pain)
03/2005
1Vomiting
03/2005
1Anorexia
03/2005
1Nausea
03/2005
1Headache (Headaches)
03/2005
1Fever (Fevers)
03/2005
1Malignant Mesothelioma
02/2005
1Exanthema (Rash)
02/2005
1Multiple Myeloma
06/2004
1Tuberculosis (Tuberculoses)
06/2002
1Latent Tuberculosis
06/2002

Drug/Important Bio-Agent (IBA)

2QuercetinIBA
01/2020 - 01/2020
2oxidized low density lipoproteinIBA
01/2020 - 01/2020
2Pemetrexed (MTA)FDA Link
06/2005 - 02/2005
2Azacitidine (5 Azacytidine)FDA Link
05/2005 - 03/2005
1Leukemia Inhibitory FactorIBA
03/2020
1Cholinergic Agents (Cholinergics)IBA
03/2020
1guizhi decoctionIBA
03/2020
1SaltsIBA
03/2020
1Nerve Growth Factor (NGF)IBA
03/2020
1Ointments (Pastes)IBA
11/2019
1HomocysteineIBA
01/2019
1AntioxidantsIBA
01/2019
1sho-seiryu-toIBA
01/2019
1CurcuminIBA
07/2014
1Biomarkers (Surrogate Marker)IBA
06/2012
1Docetaxel (Taxotere)FDA Link
06/2005
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
06/2005
1SuspensionsIBA
05/2005
1Cisplatin (Platino)FDA LinkGeneric
02/2005
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2005
1Bortezomib (Velcade)FDA Link
06/2004
1rifapentine (Priftin)FDA Link
06/2002
1Rifampin (Rifampicin)FDA LinkGeneric
06/2002
1Isoniazid (Ftivazide)FDA LinkGeneric
06/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2005 - 02/2005
1Acupuncture Points (Acupuncture Point)
06/2021
1Denervation
03/2020
1Moxibustion
11/2019
1Oral Administration
01/2019
1Injections
05/2005